(713) 352-7975

Dangerous Drugs

FDA Pushes for the Withdrawal Zantac from the U.S. Market Due to NDMA, Cancer Risks

Stop Taking & Selling Ranitidine Drugs, Urges the FDA Zantac and all generic ranitidine products should be pulled off the market immediately—and people should stop using these popular antacids—the U.S. Food and Drug Administration (FDA) announced on April 1, 2020....

Continue Reading

Valsartan-Containing Drugs Recalled Due to Possible Carcinogenic Impurities

The voluntary recall of valsartan-containing medications has recently been expanded to now include drugs made by nine different pharmaceutical companies.1 First announced on July 13th, this recall was triggered by findings of that some valsartan-containing drugs may have been contaminated...

Continue Reading

Pin It on Pinterest

Skip to content